C752 / Shanghai Sinobioway Sunterra Biotechnology - LARVOL DELTA

C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma (clinicaltrials.gov) - P1 | N=2 | Terminated | Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | N=24 ➔ 2 | Trial completion date: Dec 2025 ➔ Dec 2024 | Recruiting ➔ Terminated; Due to the PI's determination

Enrollment change • Trial completion date • Trial termination • B Cell Lymphoma • B Cell Non-Hodgkin Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology